Comparative treatment between sitagliptin vs. metformin, alone or in combination, in patients with polycystic ovary syndrome. A clinical entity at high risk for developing diabetes mellitus and gestational diabetes: A pilot study

Comparative treatment between sitagliptin vs. metformin, alone or in combination, in patients with polycystic ovary syndrome. A clinical entity at high risk for developing diabetes mellitus and gestational diabetes: A pilot study

Objective: To determine the efficacy of sitagliptin alone or in combination with metformin in women with polycystic ovary in terms of ovarian cyclicity, fertility and cardiometabolic profile compared to metformin alone. Rationale: polycystic ovarian syndrome (PCOS) affects a percentage of 5–10% of w...

Full description

Bibliographic Details
Main Authors: J.C. Paredes Palma, E. López Byhen, L. Ibáñez, L. Balladares Macedo, C. Paredes Palma, C. Ramírez Velázquez
Format: Article
Language:English
Published: Permanyer 2018-01-01
Series:Revista Médica del Hospital General de México
Subjects:
Polycystic ovarian syndrome
Diabetes mellitus
Prediabetes
Insulin resistance
Online Access:http://www.sciencedirect.com/science/article/pii/S0185106317300094

Similar Items

Similar Items